Clinic of Internal Medicine, Evangelisches Krankenhaus Oberhausen, Oberhausen, Germany.
Department of Gynecology and Obstetrics, University Hospital of Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Germany.
Arch Gynecol Obstet. 2023 Apr;307(4):1137-1143. doi: 10.1007/s00404-022-06760-5. Epub 2022 Sep 7.
BACKGROUND/PURPOSE: This study aims to investigate whether women with cervical dysplasia after LEEP have an increased risk of pregnancy/childbirth complications or recurrence of dysplasia in an upcoming pregnancy.
Data from 240 women after LEEP were analysed retrospectively. The reference group consisted of 956 singleton births. Fisher's and Wilcoxon rank tests were used to detect differences between groups. Using logistic regressions, we analysed the effect of surgery-specific aspects of LEEP on pregnancy/childbirth complications and the frequency of CIN recurrences.
We found that tissue-preserving LEEP did not lead to premature birth or miscarriage and did not increase the likelihood of CIN recurrence. We did not observe differences regarding preterm birth [< 37 (p < 0.28) < 34 (p < 0.31), < 32 weeks of gestation (p < 0.11)] or birth weight (< 2500 g (p < 0.54), < 2000 g (p < 0.77) between groups. However, women after LEEP exhibit a higher risk of premature rupture of membranes (PROM) at term (p < 0.009) and vaginal infections (p < 0.06). Neither volume nor depth of the removed tissue nor an additional endocervical resection seems to influence the likelihood of premature birth or early miscarriage. Performing an endocervical resection protects against CIN recurrence (OR 0.0881, p < 0.003).
After tissue-preserving LEEP, there is an increased risk of vaginal infections and PROM at term in consecutive pregnancy. LEEP does not affect prematurity or miscarriage. The removal of additional endocervical tissue appears to be a protective factor against recurrence of CIN.
背景/目的:本研究旨在探讨利普刀治疗后宫颈上皮内瘤变(CIN)的女性在下次妊娠时是否有更高的妊娠/分娩并发症风险或 CIN 复发风险。
回顾性分析 240 例利普刀治疗后的女性患者的数据。参考组由 956 例单胎分娩组成。采用 Fisher 确切概率法和 Wilcoxon 秩和检验比较两组间的差异。采用 logistic 回归分析利普刀手术相关因素对妊娠/分娩并发症及 CIN 复发的影响。
我们发现,保留组织的利普刀治疗不会导致早产或流产,也不会增加 CIN 复发的可能性。我们没有观察到早产[ < 37 周(p < 0.28) < 34 周(p < 0.31), < 32 周(p < 0.11)]或出生体重(< 2500 g(p < 0.54), < 2000 g(p < 0.77))在两组之间存在差异。然而,利普刀治疗后的女性在足月时胎膜早破(PROM)的风险更高(p < 0.009),阴道感染的风险更高(p < 0.06)。切除组织的体积和深度或额外的宫颈管切除术似乎都不会影响早产或早期流产的可能性。行宫颈管切除术可预防 CIN 复发(OR 0.0881,p < 0.003)。
保留组织的利普刀治疗后,连续妊娠时阴道感染和足月 PROM 的风险增加。利普刀治疗不影响早产或流产。额外切除宫颈管组织似乎是预防 CIN 复发的保护因素。